TP53 and RB1 are predictive genetic biomarkers for sensitivity to cytarabine in gliomas
Liisi Laaniste, Joachim Luginbühl, Mi K. Trinh…·Louwai Muhammed
The paper identifies TP53 and RB1 wild-type status as predictors of cytarabine sensitivity in gliomas using CRISPRi screening and machine learning analysis.